This fact sheet is your guide to frequently asked questions about ovarian cancer, including questions related to prevention, risk and hereditary factors impacting the disease.
Review Date: April 07, 2011
Ovarian Cancer National Alliance
This fact sheet describes the BRCA1 and BRCA2 genes and related link to hereditary breast and ovarian cancer. Learn what to do if a person tests positive for one of these alterations, and the consequences of genetic testing.
Review Date: January 25, 2013
NIH National Cancer Institute
Make an informed decision about your cancer treatment. Use this tool for a detailed analysis of your specific condition, statistical breakdown of treatment types, and pinpoint the exact topics you should discuss with your doctor.
Review Date: February 11, 2013
American Cancer Society
NOCC volunteers network with patients, family members, and caregivers to provide support and encouragement about ovarian cancer.
Review Date: September 08, 2011
National Ovarian Cancer Coalition, Inc.
Find a state listing of FORCE outreach networks that offer peer support and resources to people affected by hereditary breast and ovarian cancer.
Review Date: April 20, 2011
FORCE: Facing Our Risk of Cancer Empowered
Avoiding risk factors and increasing protective factors may help prevent ovarian cancer. Risk factors include hormone replacement therapy, obesity and use of fertility drugs. Protective factors include a history of oral contraceptive use, pregnancy and breast feeding.
Review Date: October 25, 2012
NIH National Cancer Institute
The National Ovarian Cancer Coalition (NOCC) offers this free kit to help support you and your family throughout the course of your disease.
Review Date: March 21, 2013
National Ovarian Cancer Coalition, Inc.
This booklet provides important information about the symptoms, diagnosis, and treatment of ovarian cancer. You will also find lists of questions to ask your doctor.
Review Date: March 21, 2013
NIH National Cancer Institute
Women with certain risk factors may be more likely than others to develop ovarian cancer. These include age (over 55), personal health history of cancer and/or menopausal hormone therapy, family history of cancer, and more.
Review Date: February 05, 2012
NIH National Cancer Institute